SAM advises Monsanto on securing CCI approval Bayer AG

Image
ANI New Delhi [India]
Last Updated : May 23 2018 | 2:15 PM IST

Shardul Amarchand Mangaldas & Co. (SAM & Co.) advised Monsanto Company on securing Competition Commission of India (CCI) approval for the USD 63 billion global acquisition of Monsanto by Bayer AG. The agreement relating to the transaction was entered into on 14 September, 2016. Post the due approvals, Monsanto shall become a subsidiary of Bayer.

The Competition Law Practice of Shardul Amarchand Mangaldas advised on the matter. The Competition Law team provided strategic advice to Monsanto and assisted Bayer in filing the Form II notification (long form notification) with the CCI, responding to information requests.

Given the importance of the agricultural sector in India and the CCI's focus on the same, the Firm assisted Monsanto in addressing concerns of the CCI through multiple discussions, and in offering modification to the transaction by way of divestitures and behavioural remedies required by the CCI.

The Competition Law practice team was led by Mr. Naval Chopra, Partner; and Ms. Aparna Mehra, Partner; and included Mr. Rohan Arora, Principal Consultant; Mr. Saattvic, Senior Economist; Mr. Aman Sethi, Senior Associate; Ms. Nitika Dwivedi, Senior Associate; Mr. Geet Sawhney, Associate; Ms. Gayatri Pradhan, Associate.

The SAM Competition Team was assisted by its General Corporate Team who are also involved in the divestment process. The team was led by Ms. Akila Agarwal, Partner; and Mr. Sourav Kanti Biswas, Partner; and included Ms. Megha Bhargawa, Principal Associate; Ms. Ishita Khandelwal, Senior Associate.

The transaction required antitrust approval from competition authorities in several jurisdictions including the European Union, United States of America, Brazil, China, Russia, and South Africa.

Other advisors to the transaction were Arnold & Porter (International counsel for Monsanto); Sullivan & Cromwell LLP(International counsel for Bayer AG); and Luthra & Luthra Law Offices (India counsel for Bayer AG).

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 23 2018 | 2:15 PM IST

Next Story